FHESX
Price
$15.11
Change
-$0.06 (-0.40%)
Updated
Jun 22 closing price
Net Assets
19.6M
RSLAX
Price
$71.21
Change
+$0.59 (+0.84%)
Updated
Jun 22 closing price
Net Assets
91.47B
Interact to see
Advertisement

FHESX vs RSLAX

FHESX vs RSLAX Comparison Chart in %
View a ticker or compare two or three
VS
FHESX vs. RSLAX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHESX is a StrongBuy and RSLAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLAX has more cash in the bank: 91.5B vs. FHESX (19.6M). FHESX pays higher dividends than RSLAX: FHESX (0.95) vs RSLAX (0.21). FHESX was incepted earlier than RSLAX: FHESX (8 years) vs RSLAX (24 years). RSLAX (1.74) is less costly to investors than FHESX (1.27). RSLAX is a more actively managed with annual turnover of: 41.00 vs. FHESX (24.00). RSLAX has a lower initial minimum investment than FHESX: RSLAX (250) vs FHESX (1000000). RSLAX annual gain was more profitable for investors over the last year : 21.98 vs. FHESX (16.01). FHESX return over 5 years is better than : 17.14 vs. RSLAX (-6.60).
FHESXRSLAXFHESX / RSLAX
Total Expense Ratio0.941.7454%
Annual Report Gross Expense Ratio1.271.7473%
Fund Existence8 years24 years-
Gain YTD10.97316.43267%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets19.6M91.5B0%
Annual Yield % from dividends0.950.21461%
Returns for 1 year16.0121.9873%
Returns for 3 years26.8138.6769%
Returns for 5 years17.14-6.60-260%
Returns for 10 yearsN/A83.31-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSGRX93.50N/A
N/A
Putnam Small Cap Growth R
PIIOX14.97N/A
N/A
Principal International Equity Index R3
EMRZX23.20N/A
N/A
VanEck Emerging Markets Z
TROIX17.90N/A
N/A
T. Rowe Price Overseas Stock I
ARTNX21.27-0.11
-0.51%
Artisan Select Equity Investor